Key result
Cardioneuroablation via epicardial PFA shows potential as an AF treatment in early studies.
Why the study?
The cardiac autonomic nervous system plays a key role in the initiation and propagation of AF, prompting development of epicardial pulsed field cardioneuroablation.
Does cardioneuroablation using epicardial pulsed field ablation treat atrial fibrillation?
Does cardioneuroablation using epicardial pulsed field ablation treat atrial fibrillation?
Epicardial pulsed field ablation is an emerging cardioneuroablation technique for modulating the cardiac autonomic nervous system to treat atrial fibrillation.
Hypothesis-generating for epicardial pulsed field ablation in cardioneuroablation; randomized trials needed before clinical adoption in atrial fibrillation.
Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting millions of people worldwide. The cardiac autonomic nervous system (ANS) is widely recognized as playing a key role in both the initiation and propagation of AF. This paper reviews the background and development of a unique cardioneuroablation technique for the modulation of the cardiac ANS as a potential treatment for AF. The treatment uses pulsed electric field energy to selectively electroporate ANS structures on the epicardial surface of the heart. Insights from in vitro studies and electric field models are presented as well as data from both pre-clinical and early clinical studies.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2023) conducted a review in Atrial Fibrillation. Cardioneuroablation using epicardial pulsed field ablation was evaluated. Cardioneuroablation using epicardial pulsed field ablation is reviewed as a potential treatment for atrial fibrillation, highlighting insights from pre-clinical and early clinical studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: